These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Cav1.3 channels control D2-autoreceptor responses via NCS-1 in substantia nigra dopamine neurons. Dragicevic E; Poetschke C; Duda J; Schlaudraff F; Lammel S; Schiemann J; Fauler M; Hetzel A; Watanabe M; Lujan R; Malenka RC; Striessnig J; Liss B Brain; 2014 Aug; 137(Pt 8):2287-302. PubMed ID: 24934288 [TBL] [Abstract][Full Text] [Related]
5. Trace amines depress GABA B response in dopaminergic neurons by inhibiting G-betagamma-gated inwardly rectifying potassium channels. Federici M; Geracitano R; Tozzi A; Longone P; Di Angelantonio S; Bengtson CP; Bernardi G; Mercuri NB Mol Pharmacol; 2005 Apr; 67(4):1283-90. PubMed ID: 15644497 [TBL] [Abstract][Full Text] [Related]
6. AMP-activated protein kinase slows D2 dopamine autoreceptor desensitization in substantia nigra neurons. Yang W; Munhall AC; Johnson SW Neuropharmacology; 2019 Nov; 158():107705. PubMed ID: 31301335 [TBL] [Abstract][Full Text] [Related]
7. Taar1-mediated modulation of presynaptic dopaminergic neurotransmission: role of D2 dopamine autoreceptors. Leo D; Mus L; Espinoza S; Hoener MC; Sotnikova TD; Gainetdinov RR Neuropharmacology; 2014 Jun; 81():283-91. PubMed ID: 24565640 [TBL] [Abstract][Full Text] [Related]
8. Trace amines inhibit the electrically evoked release of [3H]acetylcholine from slices of rat striatum in the presence of pargyline: similarities between beta-phenylethylamine and amphetamine. Baud P; Arbilla S; Cantrill RC; Scatton B; Langer SZ J Pharmacol Exp Ther; 1985 Oct; 235(1):220-9. PubMed ID: 3930699 [TBL] [Abstract][Full Text] [Related]
13. G protein-coupled inward rectifier modulated by dopamine agonists in cultured substantia nigra neurons. Kim KM; Nakajima Y; Nakajima S Neuroscience; 1995 Dec; 69(4):1145-58. PubMed ID: 8848103 [TBL] [Abstract][Full Text] [Related]
14. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems. Wachtel SR; Hu XT; Galloway MP; White FJ Synapse; 1989; 4(4):327-46. PubMed ID: 2532422 [TBL] [Abstract][Full Text] [Related]
15. The selective antagonist EPPTB reveals TAAR1-mediated regulatory mechanisms in dopaminergic neurons of the mesolimbic system. Bradaia A; Trube G; Stalder H; Norcross RD; Ozmen L; Wettstein JG; Pinard A; Buchy D; Gassmann M; Hoener MC; Bettler B Proc Natl Acad Sci U S A; 2009 Nov; 106(47):20081-6. PubMed ID: 19892733 [TBL] [Abstract][Full Text] [Related]
16. Stromal cell-derived factor-1alpha modulation of the excitability of rat substantia nigra dopaminergic neurones: presynaptic mechanisms. Guyon A; Skrzydelsi D; Rovère C; Rostène W; Parsadaniantz SM; Nahon JL J Neurochem; 2006 Mar; 96(6):1540-50. PubMed ID: 16476083 [TBL] [Abstract][Full Text] [Related]
17. Electrophysiological effects of trace amines on mesencephalic dopaminergic neurons. Ledonne A; Berretta N; Davoli A; Rizzo GR; Bernardi G; Mercuri NB Front Syst Neurosci; 2011; 5():56. PubMed ID: 21772817 [TBL] [Abstract][Full Text] [Related]
18. The clozapine metabolite N-desmethylclozapine displays variable activity in diverse functional assays at human dopamine D₂ and serotonin 5-HT₁A receptors. Heusler P; Bruins Slot L; Tourette A; Tardif S; Cussac D Eur J Pharmacol; 2011 Nov; 669(1-3):51-8. PubMed ID: 21835172 [TBL] [Abstract][Full Text] [Related]